First-in-human study of investigational SOS1 inhibitor shows encouraging safety profile and early anti-tumor activity in patients with metastatic solid tumors
Solvay will fund Pantys-led initiatives targeting vulnerable communities through product donations and menstrual health education programs
BPDCN typically presents with skin lesions before rapidly spreading to the bone marrow, lymph nodes
Adya Anubhuti launches ADHD Copilot, an AI-powered platform designed to reduce stress and mental overload
The newly licensed platform enables precise control over both the drug-to-antibody ratio and payload attachment sites in single- and dual-payload ADCs
On a full-year basis, revenue from operations for FY26 grew 18.9 percent year-on-year to Rs 827.87 crore compared to Rs 696.48 crore in FY25
The Establishment Inspection Report came following closure of a product- specific pre-approval inspection from March 2 to March 7, 2026
Company launches clinical study of AI-designed oral formulation following MHRA approval, marking a major milestone in AI-driven drug development.
These data support clinically meaningful efficacy within this patient population. We observed a high rate of complete responses in patients with laCSCC
With over three decades of extensive industry experience, Ramesh Juneja brings a strong track record of building and scaling large businesses
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
